A Deeper Insight into COL4A3, COL4A4, and COL4A5 Variants and Genotype-Phenotype Correlation of a Turkish Cohort with Alport Syndrome

被引:1
|
作者
Yavas, Cueneyd [1 ]
Ozgenturk, Nehir Ozdemir [2 ]
Dogan, Mustafa [1 ]
Gezdirici, Alper [1 ]
Keskin, Ece [3 ]
Ili, Ezgi Gokpinar [1 ]
Dogan, Tunay [4 ]
Celebi, Evrim [1 ]
Bender, Onur [5 ]
Un, Cemal [6 ]
机构
[1] Basaksehir Cam & Sakura City Hosp, Dept Med Genet, Istanbul, Turkiye
[2] Yildiz Tech Univ, Fac Arts & Sci, Dept Mol Biol & Genet, Istanbul, Turkiye
[3] Haseki Training & Res Hosp, Clin Med Genet, Istanbul, Turkiye
[4] Istinye Univ, Fac Med, Dept Pathol, Istanbul, Turkiye
[5] Ankara Univ, Biotechnol Inst, Ankara, Turkiye
[6] Ege Univ, Dept Biol, Mol Biol Sect, Fac Sci, Izmir, Turkiye
关键词
Next-generation sequencing; Alport syndrome; Kidney disease; Novel variants; Genome; NATURAL-HISTORY; DIGENIC INHERITANCE; MUTATIONS; NEPHROPATHIES; DIAGNOSIS; FAMILIES; SPECTRUM; FEATURES; IMPACT; GENES;
D O I
10.1159/000533915
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Alport syndrome (AS) is an inherited, rare, progressive kidney disease that affects the eye and ear physiology. Pathogenic variants of COL4A5 account for 85% of all cases, while COL4A3 and COL4A4 account for the remaining 15%. Methods: Targeted next-generation sequencing of the COL4A3, COL4A4, and COL4A5 genes was performed in 125 Turkish patients with AS. The patients were compared to 45 controls and open-access population data. Results: The incidence of AS variants in patients was found as 21.6%. 27 variants were identified as pathogenic/likely pathogenic, 28 as variant of uncertain significance, and 52 as benign/likely benign. We also found 31 novel variants (14 in COL4A3, 6 in COL4A4, and 11 in COL4A5) of which 27 were classified as pathogenic/likely pathogenic. Pathogenic/likely Pathogenic variants were most commonly found in the COL4A5 gene, consistent with the literature. This study contributed novel variants associated with AS to the literature. Conclusion: Genetic testing is a crucial part for the diagnosis and management of AS. Studies on the genetic etiology of AS are limited for the Turkish population. We believe that this study will contribute to the literature and the clinical decision-making process of patients with AS and emphasize the importance of genetic counseling.(c) 2023
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [1] Trigenic COL4A3/COL4A4/COL4A5 Pathogenic Variants in Alport Syndrome: A Case Report
    Rao, Dipti
    Maas, Rutger J.
    Cornelissen, Elisabeth A.
    Wetzels, Jack F.
    van Geel, Michel
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 443 - 443
  • [2] Trigenic COL4A3/COL4A4/COL4A5 Pathogenic Variants in Alport Syndrome: A Case Report
    Rao, Dipti
    Maas, Rutger
    Cornelissen, Marlies
    Wetzels, Jack
    van Geel, Michel
    [J]. NEPHRON, 2024,
  • [3] Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome
    Liu, Jian-Hong
    Wei, Xiu-Xiu
    Li, Ang
    Cui, Ying-Xia
    Xia, Xin-Yi
    Qin, Wei-Song
    Zhang, Ming-Chao
    Gao, Er-Zhi
    Sun, Jun
    Gao, Chun-Lin
    Liu, Feng-Xia
    Wu, Qiu-Yue
    Li, Wei-Wei
    Asan
    Liu, Zhi-Hong
    Li, Xiao-Jun
    [J]. PLOS ONE, 2017, 12 (05):
  • [4] Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome
    Cerkauskaite, Agne
    Savige, Judy
    Janonyte, Karolina
    Jeremiciute, Ieva
    Miglinas, Marius
    Kazenaite, Edita
    Laurinavicius, Arvydas
    Strupaite-Sileikiene, Rasa
    Vainutiene, Vija
    Burnyte, Birute
    Jankauskiene, Augustina
    Rolfs, Arndt
    Bauer, Peter
    Schroeder, Sabine
    Cerkauskiene, Rimante
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [5] Genotype–phenotype correlations for COL4A3–COL4A5 variants resulting in Gly substitutions in Alport syndrome
    Joel T. Gibson
    Mary Huang
    Marina Shenelli Croos Dabrera
    Krushnam Shukla
    Hansjörg Rothe
    Pascale Hilbert
    Constantinos Deltas
    Helen Storey
    Beata S. Lipska-Ziętkiewicz
    Melanie M. Y. Chan
    Omid Sadeghi-Alavijeh
    Daniel P. Gale
    Agne Cerkauskaite
    Judy Savige
    [J]. Scientific Reports, 12
  • [6] ADPKD and collagen genes (COL4A3, COL4A4, COL4A5)
    Caprara, Carlotta
    Corradi, Valentina
    Rigato, Matteo
    Mancini, Barbara
    Marzano, Nenzi
    Perbellini, Omar
    Gastaldon, Fiorella
    Ronco, Claudio
    Zanella, Monica
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1962 - I1962
  • [7] Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome
    Wang, Duocai
    Pan, Meize
    Li, Hang
    Li, Minchun
    Li, Ping
    Xiong, Fu
    Xiao, Hongbo
    [J]. BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [8] Trimerization and Genotype-Phenotype Correlation of COL4A5 Mutants in Alport Syndrome
    Kamura, Misato
    Yamamura, Tomohiko
    Omachi, Kohei
    Suico, Mary Ann
    Nozu, Kandai
    Kaseda, Shota
    Kuwazuru, Jun
    Shuto, Tsuyoshi
    Iijima, Kazumoto
    Kai, Hirofumi
    [J]. KIDNEY INTERNATIONAL REPORTS, 2020, 5 (05): : 718 - 726
  • [9] Alport综合征家系COL4A3、COL4A4、COL4A5基因突变分析
    何威
    李文成
    孙丽娟
    邱桂霞
    徐建峰
    马媛媛
    王伟光
    [J]. 国际医药卫生导报, 2019, (23) : 3823 - 3826
  • [10] Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport Syndrome using next generation sequence technique
    Zhao, Xuechao
    Chen, Chen
    Wei, Yanfu
    Zhao, Ganye
    Liu, Lina
    Wang, Conghui
    Zhang, Junjun
    Kong, Xiangdong
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (06):